The Impact of Marijuana Pharmaceuticals
John Robert Alfino
September 15, 2013
FDA will soon approve Sativex, the first marijuana-based pharmaceutical. Sativex is a tipping point in the marijuana law and the politics of strict prohibition. The reclassification of marijuana under the Controlled Substances Act is in the financial interests of the American pharmaceutical industry. The availability of marijuana-based, or synthetic cannabinoid-based, pharmaceuticals will change the politics of marijuana prohibition.
Number of Pages in PDF File: 6
Keywords: marijuana, Sativex, cannabinoidworking papers series
Date posted: September 16, 2013
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo4 in 0.297 seconds